Arboleda-Velasquez, J.F., Lopera, F., O’Hare, M. et al. Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report. Nat Med (2019) doi:10.1038/s41591-019-0611-3
Ramirez-Aguilar L, Acosta-Uribe J, Giraldo MM, Moreno S, Baena A, Alzate D, Cuastumal R, Aguillón D, Madrigal L, Saldarriaga A, Navarro A, Garcia GP, Aguirre-Acevedo DC, Geier EG, Cochran JN, Quiroz YT, Myers RM, Yokoyama JS, Kosik KS, Lopera F. Genetic origin of a large family with a novel PSEN1 mutation (ILE416THR). Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. 2019; 14 (5): 709-719
Hanseeuw BJ, Lopera F, Sperling RA, Norton DJ, Guzman-Velez E, Baena A, Pardilla-Delgado E, Schultz AP, Gatchel J, Jin D, Chen K, Reiman EM, Johnson KA, Quiroz YT. Striatal amyloid is associated with tauopathy and memory decline in familiar Alzheimer’s disease. Alzheimers Res Ther. 2019; 11 (17): 1-6.
Fuller JT, Cronin-Golomb A, Gatchel JR, Norton DJ, Guzmán-Vélez E, Jacobs HIL, Hanseeuw B, Pardilla-Delgado E, Artola A, Baena A, Bocanegra Y, Kosik KS, Chen K, Tariot PN, Johnson K, Sperling RA, Reiman EM, Lopera F, Quiroz YT. Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer’s Disease: A Comprehensive Review of the Colombian Kindred. J Alzheimer’s Dis 2018 Dec; 6: 1-9.
Guzmán-Vélez E*, Jaimes S*, Aguirre-Acevedo DC, Norton DJ, Papp KV, Rebecca Amariglio R, Rentz D, Baena A, Henao E, Tirado V, Muñoz C, Giraldo M, Sperling RA, Lopera F, and Quiroz YT. A Three-Factor Structure of Cognitive Functioning Among Unimpaired Carriers and Non-Carriers of Autosomal-Dominant Alzheimer’s Disease. J Alzheimer’s Dis 2018 Jun; 65: 107-115. doi: 10.3233/JAD-180078 *Contributed equally
Aguirre-Acevedo DC, Lopera F, Henao E, Tirado V, Muñoz C, Giraldo M, Bangdiwala SI, Reiman EM, Tariot PN, Langbaum JB, Quiroz YT, Jaimes F. Cognitive Decline in a Colombian Kindred With Autosomal Dominant Alzheimer Disease: A Retrospective Cohort Study. JAMA Neurol. 2016 Apr;73(4):431-8. doi: 10.1001/jamaneurol.2015.4851.
Quiroz YT, Schultz A, Chen K, Protas H, Brickhouse M, Fleisher AS, Langbaum JB, Thiyyagura P, Fagan AM, Shah AR, Muniz M, Arboleda-Velasquez JF, Munoz C, Garcia G, Acosta-Baena N, Giraldo M, Tirado V, Ramirez D, Tariot PN, Dickerson BC, Sperling RA, Lopera F, Reiman EM. Brain imaging and blood biomarker abnormalities in children with autosomal-dominant Alzheimer’s disease: A cross-sectional study. JAMA Neurol 2015 Aug 1; 72(8):912-919. doi: 10.1001/jamaneurol.2015.1099.
Quiroz YT, Willment KC, Castrillon G, Muniz M, Lopera F, Budson AE, Stern C. Successful scene encoding in presymptomatic early-onset Alzheimer’s disease. J Alzheimer’s Dis 2015; vol. 47, no. 4, pp. 955-964
Fleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gutierrez-Gomez M, Langois CM, Langbaum JBS, Roontiva A, Thiyyagura P, Lee W, Ayutyanont N, Lopez L, Moreno S, Munoz C, Tirado V, Acosta-Baena N, Fagan AM, Giraldo M, Garcia G, Huentelman MJ, Tariot PN, Lopera F, Reiman EM. Associations between biomarkers and age in the presenilin-1 E280A autosomal dominant Alzheimer’s disease kindred: a cross-sectional study. JAMA Neurol 2015; Jan 12. doi: 10.1001/jamaneurol.2014.3314.
Rodriguez R, Lopera F, Alvarez A, Fernandez Y, Galan L, Quiroz YT, Bobes MA. Spectral analysis of EEG in familial Alzheimer’s disease due to E280A presenilin-1 mutation. Int Alzheimer’s Dis 2014; 2014:180741.
Quiroz YT, Stern CE, Reiman EM, Brickhouse M, Ruiz A, Sperling RA, Lopera F, Dickerson BC. Alzheimer’s disease-signature cortical atrophy in presymptomatic AD presenilin-1 mutation carriers. J Neurol Neurosurg Psychiatry 2013; 84(5): 556-561
Reiman EM*, Quiroz YT*, Fleisher AS, Chen K, Velez-Pardo C, Jimenez-Del-Rio M, Fagan AM, Shah AR, Alvarez S, Arbelaez A, Giraldo M, Acosta-Baena N, Sperling RA, Dickerson BC, Stern CE, Tirado V, Munoz C, Reiman RA, Huentelman MJ, Alexander GE, Langbaum JBS, Kosik KS, Tariot PN, Lopera F. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer’s disease in the presenilin 1 E280A kindred: a case-control study. Lancet Neurol 2012; 11(12):1048-1056. *Contributed equally
Fleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gomez MG, Langois CM, Langbaum JB, Ayutyanont N, Roontiva A, Thiyyagura P, Lee W, Mo H, Lopez L, Moreno S, Acosta-Baena N, Giraldo M, Garcia G, Reiman RA, Huentelman MJ, Kosik KS, Tariot PN, Lopera F, Reiman EM. Florbetapir PET analysis of amyloid-ß deposition in the presenilin 1 E280A autosomal dominant Alzheimer’s disease kindred: a cross-sectional study. Lancet Neurol. 2012 Dec; 11(12):1057-65.
Quiroz YT, Ally BA, Celone K, Mckeever J, Ruiz A, Lopera F, Stern CE, Budson AE. Event-related potential markers of brain changes in preclinical familial Alzheimer’s disease. Neurology 2011; 77(5): 469-475.
Quiroz YT, Budson AE, Celone K, Ruiz A, Castrillon G, Lopera F. Hippocampal hyperactivation in pre-symptomatic familial Alzheimer’s disease. Ann Neurol 2010; 68 (6): 865-875.
